Sagent Pharmaceuticals Sets Date and Time for Release of Fourth Quarter and Full Year 2015 Financial Results
February 03, 2016 16:00 ET
|
Sagent Pharmaceuticals, Inc.
SCHAUMBURG, Ill., Feb. 03, 2016 (GLOBE NEWSWIRE) -- Sagent Pharmaceuticals, Inc. (NASDAQ:SGNT) a leader of specialty pharmaceutical products with a specific emphasis on the injectable market, today...
Sagent Pharmaceuticals Receives Innovative Technology Designation From Novation for GLYDO® (Lidocaine HCl Jelly USP, 2%)
January 12, 2016 08:00 ET
|
Sagent Pharmaceuticals, Inc.
SCHAUMBURG, Ill., Jan. 12, 2016 (GLOBE NEWSWIRE) -- Sagent Pharmaceuticals, Inc. (Nasdaq:SGNT) announced its GLYDO® (lidocaine HCl jelly USP, 2%) has received Innovative Technology designation from...
Sagent Pharmaceuticals to Present at 34th Annual J.P. Morgan Healthcare Conference
January 08, 2016 12:55 ET
|
Sagent Pharmaceuticals, Inc.
SCHAUMBURG, Ill., Jan. 08, 2016 (GLOBE NEWSWIRE) -- Sagent Pharmaceuticals, Inc. (NASDAQ:SGNT), a leader of specialty pharmaceutical products with an emphasis on the injectable market, today...
Sagent Pharmaceuticals Reports Third Quarter 2015 Financial Results
November 03, 2015 07:00 ET
|
Sagent Pharmaceuticals, Inc.
Company Affirms 2015 Full Year Guidance Allan Oberman Assumes Role of Chief Executive Officer effective September 12, 2015 SCHAUMBURG, Ill., Nov. 03, 2015 (GLOBE NEWSWIRE) -- Sagent...
Sagent Pharmaceuticals Announces the Launch of Chlorothiazide Sodium for Injection, USP
October 27, 2015 16:05 ET
|
Sagent Pharmaceuticals, Inc.
SCHAUMBURG, Ill., Oct. 27, 2015 (GLOBE NEWSWIRE) -- Sagent Pharmaceuticals, Inc. (NASDAQ:SGNT) today announced the launch of Chlorothiazide Sodium for Injection, USP, a diuretic/antihypertensive...
Sagent Pharmaceuticals Sets Date and Time for Release of Third Quarter 2015 Results
October 20, 2015 16:00 ET
|
Sagent Pharmaceuticals, Inc.
SCHAUMBURG, Ill., Oct. 20, 2015 (GLOBE NEWSWIRE) -- Sagent Pharmaceuticals, Inc. (NASDAQ:SGNT) a leader of specialty pharmaceutical products with a specific emphasis on the injectable market, today...
Sagent Pharmaceuticals Reports Second Quarter 2015 Financial Results
August 04, 2015 07:00 ET
|
Sagent Pharmaceuticals, Inc.
Company to evaluate strategic alternatives for Sagent (China) Pharmaceuticals
Company modifies earnings guidance for 2015
SCHAUMBURG, Ill., Aug. 4, 2015 (GLOBE NEWSWIRE) -- Sagent...
Sagent Pharmaceuticals Board Appoints Allan Oberman as Chief Executive Officer
August 03, 2015 16:25 ET
|
Sagent Pharmaceuticals, Inc.
SCHAUMBURG, Ill., Aug. 3, 2015 (GLOBE NEWSWIRE) -- Sagent Pharmaceuticals, Inc. (NASDAQ:SGNT) a leader of specialty pharmaceutical products with a specific emphasis on the injectables market, today...
Sagent Pharmaceuticals Sets Date and Time for Release of Second Quarter 2015 Results
July 28, 2015 08:00 ET
|
Sagent Pharmaceuticals, Inc.
SCHAUMBURG, Ill., July 28, 2015 (GLOBE NEWSWIRE) -- Sagent Pharmaceuticals, Inc. (NASDAQ:SGNT), a leader of specialty pharmaceutical products with a specific emphasis on the injectable market, today...
Sagent Pharmaceuticals Reports First Quarter 2015 Financial Results
May 05, 2015 07:00 ET
|
Sagent Pharmaceuticals, Inc.
SCHAUMBURG, Ill., May 5, 2015 (GLOBE NEWSWIRE) -- Sagent Pharmaceuticals, Inc. (Nasdaq:SGNT), a leader of specialty pharmaceutical products with a specific emphasis on the injectable market, today...